Serum-induced differentiation of glioblastoma neurospheres leads to enhanced migration/invasion capacity that is associated with increased MMP9

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Joseph, Justin V ^a   Van Roosmalen, Ingrid A M ^a   Busschers, Ellen ^a   Tomar, Tushar ^a   Conroy, Siobhan ^a   Eggens Meijer, Ellie ^a   Fajardo, Natalia Peñaranda ^a   Pore, Milind M ^a   Balasubramanyian, Veerakumar ^a   Wagemakers, Michiel ^a   Copray, Sjef ^a   Den Dunnen, Wilfred F A ^a   Kruyt, Frank A E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL ACTIVATION; CELL ASSAY; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL INFILTRATION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME INHIBITION; GLIOBLASTOMA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; CELL CULTURE TECHNIQUE; CHEMISTRY; HUMAN; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; SERUM; TUMOR CELL LINE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM INVASIVENESS; SERUM;

EID: 84970922698     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145393     Document Type: Article

References (48)

1. Holland EC. Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 2000; 97(12): 6242-4. PMID: 10841526
2. Chen J, McKay RM, Parada LF. Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell. 2012; 149(1): 36-47. doi: 10.1016/j.cell.2012.03.009 PMID: 22464322
3. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63(18): 5821-8. PMID: 14522905
4. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004; 432(7015): 396-401. PMID: 15549107
5. Lathia JD, Gallagher J, Myers JT, Li M, Vasanji A, McLendon RE, et al. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells. PLoS One. 2011; 6(9): e24807. doi: 10.1371/journal. pone.0024807 PMID: 21961046
6. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9(5): 391-403. PMID: 16697959
7. Laks DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, et al. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells. 2009; 27(4): 980-7. doi: 10.1002/stem.15 PMID: 19353526
8. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004; 64(19): 7011-21. PMID: 15466194
9. Vescovi AL, Galli R, Gritti A. The neural stem cells and their transdifferentiation capacity. Biomed Pharmacother. 2001; 55(4): 201-5. PMID: 11393806
10. Gritti A, Parati EA, Cova L, Frolichsthal P, Galli R, Wanke E, et al. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci. 1996; 16(3): 1091-100. PMID: 8558238
11. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene. 2004; 23(58): 9392-400. PMID: 15558011
12. Cheng L, Bao S, Rich JN. Potential therapeutic implications of cancer stem cells in glioblastoma. Biochem Pharmacol. 2010; 80(5): 654-65. doi: 10.1016/j.bcp.2010.04.035 PMID: 20457135
13. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120): 756-60. PMID: 17051156
14. Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, et al. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol. 2014; 15(9): e395-403. doi: 10.1016/S1470-2045(14)70011-7 PMID: 25079102
15. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J.Clin Oncol. 2003; 21(8): 1624-36. PMID: 12697889
16. Walter E. Dandy. Removal of right cerebral hemisphere for certain tumors with hemiplegia. JAMA. 1928; 90(11): 823-825
17. Gardner WJ. Removal of the right cerebral hemisphere for infiltrating glioma. JAMA 1933; 12: 154-64
18. Miao H, Gale NW, Guo H, Qian J, Petty A, Kaspar J, et al. EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.Oncogene. 2014. doi: 10.1038/onc.2013.590
19. Rath BH, Fair JM, Jamal M, Camphausen K, Tofilon PJ. Astrocytes enhance the invasion potential of glioblastoma stem-like cells. PLoS One.2013; 8(1): e54752. doi: 10.1371/journal.pone.0054752 PMID: 23349962
20. Elevated invasive potential of glioblastoma stem cells. Cheng L, Wu Q, Guryanova OA, Huang Z, Huang Q, Rich JN et al. Biochem Biophys Res Commun. 2011; 406(4): 643-8. doi: 10.1016/j.bbrc. 2011.02.123 PMID: 21371437
21. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005; 5(9): 744-9. PMID: 16148886
22. Malanchi I, Santamaria-Martínez A, Susanto E, Peng H, Lehr HA, Delaloye JF, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011; 481 (7379): 85-9. doi: 10.1038/nature10694 PMID: 22158103
23. Joseph JV, Conroy S., Tomar T, Eggens-Meijer E, Bhat K, Copray S, et al. TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion. Cell Death and Disease. (2014) 5, e1443. doi: 10.1038/cddis.2014.395 PMID: 25275602
24. Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, et al. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell. 2013; 24(3): 331-46. doi: 10.1016/j.ccr.2013.08.001 PMID: 23993863
25. Eichenbaum KD, Eichenbaum JW, Fadiel A, Miller DC, Demir N, Naftolin F, et al. Minimally invasive method for murine brain fixation. Biotechniques. 2005; 39(4): 487-8, 490. PMID: 16235560
26. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell. 2009; 4(6): 568-80. doi: 10.1016/j.stem.2009.03.014 PMID: 19497285
27. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006; 25(1): 9-34. PMID: 16680569
28. Liu L, Wu J, Ying Z, Chen B, Han A, Liang Y, et al. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res. 2010; 70(9): 3750-9. doi: 10.1158/0008-5472.CAN-09-3838 PMID: 20388776
29. Nakada M, Okada Y, Yamashita J. The role of matrix metalloproteinases in glioma invasion. Front Biosci. 2003; 8: e261-9. PMID: 12456313
30. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A, et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation. 1999; 99(23): 3063-70. PMID: 10368126
31. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer. 2006; 6(6): 425-36. PMID: 16723989
32. Das G, Shiras A, Shanmuganandam K, Shastry P. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells. Mol Carcinog. 2011; 50(6): 412-23. doi: 10. 1002/mc.20723 PMID: 21557327
33. Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH, Chen GL, et al. MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci. 2014; 105(3): 265-71. doi: 10.1111/cas.12351 PMID: 24418124
34. Wang M, Wang T, Liu S, Yoshida D, Teramoto A. The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades. Brain Tumor Pathol. 2003; 20(2): 65-72. PMID: 14756443
35. Ocaña OH, Córcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 2012; 22 (6): 709-24. doi: 10.1016/j.ccr.2012.10.012 PMID: 23201163
36. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell. 2012; 22(6): 725-36. doi: 10.1016/j.ccr.2012.09.022 PMID: 23201165
37. Brabletz T. EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell. 2012; 22 (6): 699-701. doi: 10.1016/j.ccr.2012.11.009 PMID: 23238008
38. Weber K, Paulus W, Senner V. The side population of gliomas exhibits decreased cell migration. J Neuropathol Exp Neurol. 2010; 69(6): 623-31. doi: 10.1097/NEN.0b013e3181e04739 PMID: 20467330
39. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res. 2010; 16(10): 2715-28. doi: 10. 1158/1078-0432.CCR-09-1800 PMID: 20442299
40. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med. 2005; 353(8): 811-22. PMID: 16120861
41. van Strien ME, van den Berge SA, Hol EM. Migrating neuroblasts in the adult human brain: a stream reduced to a trickle. Cell Res. 2011; 21(11): 1523-5. doi: 10.1038/cr.2011.101 PMID: 21691300
42. Whitman MC, Greer CA. Adult neurogenesis and the olfactory system. Prog Neurobiol. 2009; 89 (2): 162-75. doi: 10.1016/j.pneurobio.2009.07.003 PMID: 19615423
43. Lang B, Liu HL, Liu R, Feng GD, Jiao XY, Ju G. Astrocytes in injured adult rat spinal cord may acquire the potential of neural stem cells. Neuroscience. 2004; 128(4): 775-83. PMID: 15464285
44. Yang H, Cheng XP, Li JW, Yao Q, Ju G. De-differentiation response of cultured astrocytes to injury induced by scratch or conditioned culture medium of scratch-insulted astrocytes. Cell Mol Neurobiol. 2009; 29(4): 455-73. doi: 10.1007/s10571-008-9337-3 PMID: 19130217
45. Xie Q, Mittal S, Berens ME. Targeting adaptive glioblastoma: an overview of proliferation and invasion. Neuro Oncol. 2014; 16(12): 1575-84. doi: 10.1093/neuonc/nou147 PMID: 25082799
46. Wick W, Stupp R, Beule AC, Bromberg J, Wick A, Ernemann U, et al. A novel tool to analyze MRI recurrence patterns in glioblastoma. Neuro Oncol. 2008; 10(6): 1019-24. doi: 10.1215/15228517-2008-058 PMID: 18676355
47. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859): 105-11. PMID: 11689955
48. Eyler CE, Rich JN. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol. 2008; 26(17): 2839-45. doi: 10.1200/JCO.2007.15.1829 PMID: 18539962